Update on fibroblast growth factor 23 in chronic kidney disease
Top Cited Papers
Open Access
- 1 October 2012
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 82 (7), 737-747
- https://doi.org/10.1038/ki.2012.176
Abstract
No abstract availableKeywords
This publication has 135 references indexed in Scilit:
- Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cellsBiochemical and Biophysical Research Communications, 2011
- Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney diseaseJournal of Bone and Mineral Research, 2011
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney DiseaseJAMA, 2011
- Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart diseaseAmerican Heart Journal, 2011
- FGF-23: More than a regulator of renal phosphate handling?Journal of Bone and Mineral Research, 2010
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly populationAtherosclerosis, 2009
- The impact of diabetes mellitus on vitamin D metabolism in predialysis patientsBone, 2009
- Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: Another form of FGF23-related hypophosphatemiaBone, 2009
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the communityAtherosclerosis, 2009
- Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in menBone, 2007